Skip to main content
Signal8

Quirk Gerald E

SEC insider (Form 3/4/5 filer). CIK 0001479603. Chief Legal & Compliance Offic at Syros Pharmaceuticals, Inc. (SYRS). 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 19, 2024. Located in CAMBRIDGE, MA.

Companies Quirk Gerald E has filed insider reports for

  • Syros Pharmaceuticals, Inc. (SYRS): Officer, Chief Legal & Compliance Offic
Quirk Gerald E profile photo

Quirk Gerald E

CIK: 0001479603

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Syros Pharmaceuticals, Inc. logo
SYRS

Syros Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Nov 19, 2024
    Sale
    Direct
    46.7K shares at avg. $0.22$10K
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Sep 30, 2024
    Exercise
    Direct
    10K shares-
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Sep 30, 2024
    Tax Payment
    Direct
    3.1K shares at avg. $2.10$7K

1-3 of 3